You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. PowerCube: Integrated Power, Propulsion, and Pointing for CubeSats

    SBC: TETHERS UNLIMITED, INC.            Topic: S402

    The PowerCube is a 1U CubeSat module that provides integrated propulsion, power, and precision pointing to enable the low-cost CubeSat platform to be used to conduct high-performance missions. The PowerCube concept integrates three innovative component technologies to provide these capabilities: First, a Proton Exchange Membrane (PEM) water-electrolysis fuel cell supplies gH2/gO2 to a simple pres ...

    SBIR Phase II 2012 National Aeronautics and Space Administration
  2. Ionomer-membrane Water Processor System Design and EDU Demonstration

    SBC: PARAGON SPACE DEVELOPMENT CORPORATION            Topic: X301

    a. Paragon Space Development Corporation¿ (Paragon) proposes to continue our investigation into the use of microporous-ionomer membrane technology to improve the robustness and effectiveness and simplify water recovery processes for space applications. Improved robustness and effectiveness will be evident through (1) reduced loading onthe downstream post processor due to the ionomer¿s unique pr ...

    SBIR Phase II 2012 National Aeronautics and Space Administration
  3. Life Science Research Sample Transfer Technology for On Orbit Analysis

    SBC: TECHSHOT, INC.            Topic: O302

    With retirement of the space shuttle program, microgravity researchers can no longer count on bringing experiment samples back to earth for post-flight analysis. Locker-sized processing facilities, which were typically transported up to and down from the International Space Station during the shuttle era, quite simply consume too much volume, mass, and power to be accommodated as part of both the ...

    SBIR Phase II 2012 National Aeronautics and Space Administration
  4. Frequency-Locked Single-Frequency Fiber Laser at 2 Micron

    SBC: ADVALUE PHOTONICS INC            Topic: S101

    Frequency-locked single-frequency 2 micron fiber laser is proposed to be used for airborne/spaceborne coherent lidar measurements, i.e., Active Sensing of CO2 Emissions over Nights, Days, and Seasons. The laser is based on our proprietary fiber technology and extensive experience in fiber laser development, which features a compact, highly stable, frequency-stabilized light source. Advanced freque ...

    SBIR Phase II 2012 National Aeronautics and Space Administration
  5. Multi-Specimen Variable-G Facility for Life and Microgravity Sciences Research

    SBC: TECHSHOT, INC.            Topic: O302

    The Multi-specimen Variable-G Facility (MVF) is a single locker sized centrifuge facility for life and microgravity sciences research on the International Space Station. The MVF is a rear breather EXPRESS Rack payload that leverages many of the existing subsystems of flight proven (STS-108) Avian Development Facility (ADF) thereby reducing costs and time to flight for new scientific capability. ...

    SBIR Phase II 2012 National Aeronautics and Space Administration
  6. Whole-brain fluorescence and brightfield imaging at single-cell level

    SBC: DMetrix, Inc            Topic: NIA

    DESCRIPTION (provided by applicant): The goal of this project is to develop an open and flexible imaging platform capable of rapid, 0.5- 5 m pixel resolution image capture of large-area histology sections (up to 125 mm by 175 mm), in brightfield and by epi-fluorescence optical sectioning. The project involves state-of-the- art instrumentation development coupled with application programming inter ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  7. Effect of ScanCap Technology on Medication Adherence and Hypertension Outcomes

    SBC: Concordance Health Solutions, Inc.            Topic: NIA

    DESCRIPTION (provided by applicant): In this Phase II SBIR project, Concordance Health Solutions (CHS) will continue development of the ScanCap System and test its effectiveness on adherence rates and hypertension patient outcomes The ScanCap System is anelectronic reminder cap that is seamlessly programmed at the pharmacy and incorporated into original packaging for prescription medications. The ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  8. Development of NMUR2 Antagonists as Novel Analgesics

    SBC: OMEROS CORPORATION            Topic: NIDA

    DESCRIPTION (provided by applicant): Pain affects over 100 million Americans annually. Opioids are the primary drugs that can treat pain. However, these drugs produce severe and unwanted side effects, such as respiratory depression, nausea, constipation and tolerance development (Berde et al, 2008); in addition, they are highly addictive (Koob et al, 1998). There is clearly a large, unmet need for ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  9. Overcoming Tramadol Resistance In CYP2D6 Poor Metabolizers

    SBC: Syntrix Biosystems, Inc.            Topic: NIDA

    DESCRIPTION (provided by applicant): Tramadol is a widely prescribed analgesic, with over 25 million prescriptions and 565 million in retail sales in 2009, making it among the best selling generic drugs. One of the advantages of tramadol over traditionalopioids is its lower risk of opioid dependence, resulting in it having an unscheduled status in the U.S. and other countries. Although its mode ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  10. Obese diabetic (type II) mouse model without leptin/leptin-receptor defects

    SBC: PRECLINOMICS, INC.            Topic: NIDDK

    DESCRIPTION (provided by applicant): An estimated 23.6 million people (7 percent of the population) in the United States have diabetes; 90 to 95 percent of all diagnosed cases are type 2 diabetes (CDC, 2007). Obesity and metabolic syndrome are the leadingcauses of type 2 diabetes. The search for new and more effective therapies to address the growing number of Americans with type 2 diabetes and re ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government